Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Using Whole Body MRI to Improve Cancer Detection

Official title: Whole Body MRI in Oncology

Run by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · NCT06895291 · Data updated 2026-11-12

This study is testing if Whole Body MRI can help find bone and soft tissue problems in people with different types of cancer, like lymphoma and advanced prostate and breast cancer.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Academic / other
Drugs / interventionsradiation
Locations3 sites (Bologna, BO and 2 other locations)
StatusRecruiting
StartedOctober 26, 2023
Main results expectedOctober 2028
Study endsOctober 2031
Registry record updatedMarch 30, 2025
Trial IDNCT06895291 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with specific cancers who are eligible for WB-MRI according to clinical practice.

Probably not a fit

Patients with MRI-unsafe prostheses or devices, or those unable to complete the MRI, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of Whole Body Magnetic Resonance Imaging (WB-MRI) in detecting bone and soft tissue pathology in patients with various cancers, including lymphoma and advanced prostate and breast cancer. Patients will undergo WB-MRI as part of their routine clinical care without any additional procedures. The study aims to assess the imaging technique's ability to provide high-quality morphological images and functional information about tissue cellularity. The findings could help establish WB-MRI as a standard imaging method in oncology.

Why it matters

Potential benefit: If successful, this study could enhance cancer detection and monitoring, leading to better patient outcomes.

How similar studies have gone: Previous studies have shown promising results with WB-MRI in oncology, indicating its potential as a valuable imaging technique.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
* Participant is willing and able to give informed consent for participation in the study.
* Male or Female, aged ≥ 18 years.
* Life expectancy greater than 3 months.

Exclusion Criteria:

* Patients with MRI-unsafe prostheses and devices.
* Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.

Where it's running

  • IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola
    Bologna, Bo, Italy
    Recruiting
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
    Meldola, Fc, Italy
    Recruiting
  • IRCCS Istituto Europeo di Oncologia S.r.l.
    Milan, Mi, Italy
    Not yet recruiting

Study contacts

  • Principal investigator: Alice Rossi — IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
  • Study coordinator: Oriana Nanni
  • Email: cc.ubsc@irst.emr.it
  • Phone: +390543739266

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.